Showing results (2091-2100 of 3,327) with videos related to
Sort By:
Pageof 333
Clinical Calcium|November 8, 2005
[Treatment with phosphate binder (sevelamer hydrochloride, calcium carbonate) based on PTH]Megumi Sato, Sawako Fukazawa, Takuji Yasuda, et al.Clinical Calcium|November 8, 2005
[Fibroblast growth factor (FGF)-23 in patients with hypoparathyroidism]Hiroyuki Yamashita, Shiro Noguchi, Yuji Yamasaki, et al.Clinical Calcium|November 8, 2005
[Two patients with hyperparathyroidism which was progressive for more than ten years after successful kidney transplantation]Nobuaki Uno, Yoshihiro Tominaga, Tetsuhiko Sato, et al.Clinical Calcium|November 8, 2005
[Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics]Masahide Mizobuchi, Fumie Saji, Kazuhiro Shiizaki, et al.Clinical Calcium|November 8, 2005
[Suspected case of pseudohypoparathyroidism type II]Yukihiro Kitai, Takehisa Yamamoto, Masaru Iwaki, et al.Clinical Calcium|November 8, 2005
[Suitable examination intervals for hemodialysis patients with secondary hyperparathyroidism treated with maxacalcitol]Yoshihiro Yamada, Masahiro Kumafuji, Takanori Sodeyama, et al.Clinical Calcium|November 8, 2005
[Acute response of serum PTH and bone markers after injection of 1alpha,25 (OH)2D3 and 22-oxacalcitrol in hemodialysis patient]Genichi Shimizu, Shinji Mitani, Shin Matsumoto, et al.Clinical Calcium|November 8, 2005
[Effect of vitamin D on remaining kidney function after chronic kidney failure in preservation period patient]Daijo Inaguma, Miho Tatematsu, Hibiki Shinjo, et al.Clinical Calcium|January 6, 2010
[Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers]Einosuke Mizuta, Toshihiro Hamada, Osamu Igawa, et al.Clinical Calcium|January 6, 2010
[Calcium antagonists: current and future applications based on new evidence. Renal protective action of calcium channel blockers]Genjiro KimuraPageof 333